The Bull Strangle Newsletter, released weekly, shares a trading strategy that has achieved a documented 76%-win rate and outperformed the S&P 500 by 240% since inception. The strategy combines buying stock and simultaneously selling out-of-the-money covered calls and cash-secured puts to generate option premiums and manage risk.
Watch List Favorites
This week the Newsletter contains 18 stocks across 8 sectors plus 4 uncorrelated ETF’s. 2 of the stocks on the Watch List are detailed below:
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
- KE Holdings Inc., through its subsidiaries, engages in operating an integrated online and offline platform for housing transactions and services in the People's Republic of China.
Past Performance
Each week the Newsletter contains around 20 stocks / ETF's on the Watch List to be opened the following Monday for expiration 4 Fridays later. Since the expiration cycle on May 23, the average stock gain on the Watch List has outperformed the S&P 500 18 of 19 weeks. The average Watch List to S&P 500 ratio currently sits at 2.92 : 1 in favor of the Watch List.
More Information
For a short video explaining the Bull Strangle strategy.
For a more detail on the strategy
To subscribe to the Bull Strangle Newsletter
Contact
Darren Carlat
Managing Director
Darren@SpreadEdgeCapital.com
(214) 636-3133
Disclaimer
This information is for informational purposes only and should not be considered as investment advice. Past performance is not indicative of future results, and all investments carry inherent risk. Consult with a financial advisor before making any investment decisions.
/AI%20(artificial%20intelligence)/Ai%20chip%20by%20Quality%20Stock%20Arts%20via%20Shutterstock.jpg)
/A%20close-up%20of%20the%20Broadcom%20logo%20on%20a%20smartphone%20by%20Timon%20via%20Adobe%20Stock.jpeg)